Cost-effectiveness of liposomal cytarabine-daunorubicin (CPX-351) compared to conventional cytarabine-daunorubicin chemotherapy in acute myeloid leukemia Meeting Abstract
| Authors: | Bewersdorf, J. P.; Goshua, G.; Patel, K. K.; Shallis, R. M.; Podoltsev, N.; Huntington, S. F.; Zeidan, A. M. |
| Abstract Title: | Cost-effectiveness of liposomal cytarabine-daunorubicin (CPX-351) compared to conventional cytarabine-daunorubicin chemotherapy in acute myeloid leukemia |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398800111 |
| DOI: | 10.1182/blood-2021-144992 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 113 -- Hybrid meeting, also took place online -- Source: Wos |
